Rational design of heat stable lyophilized rotavirus vaccine formulations
To develop a safe and efficacious heat-stable rotavirus vaccine, new lyophilized formulations were developed using rotavirus serotypes constituting RotaTeq®. A series of formulation compositions, differing in buffering agents, bulking agents, cryoprotectants, amino acids and divalent cations, were s...
Main Authors: | Madhu Madan, Deepa Sikriwal, Gaurav Sharma, Nidhi Shukla, Ashwani Kumar Mandyal, Sachin Kale, Davinder Gill |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-09-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2018.1487499 |
Similar Items
-
Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?
by: Jacqueline Deen, et al.
Published: (2018-02-01) -
A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants
by: Catherine Cohet, et al.
Published: (2021-11-01) -
Results and prospects of rotavirus immunisation in the Russian Federation
by: A. S. Korovkin, et al.
Published: (2023-12-01) -
The Incidence of Rotavirus in 0-5 Years Old Children and Parents' Knowledge Levels and Applications for Rotavirus
by: Tülay Ayyıldız, et al.
Published: (2020-07-01) -
Comparison of the Demographics and Ratio of Rotavirus-Associated Benign Convulsions with Mild Gastroenteritis to Rotavirus Gastroenteritis before and after Rotavirus Vaccination over a Period of 20 Years
by: Yeong Seok Lee, et al.
Published: (2021-04-01)